TY - JOUR
T1 - From the antigen-presenting cell to the antigen-presenting vesicle
T2 - The exosomes
AU - Célestin Schartz, Noël Emile
AU - Chaput, Nathalie
AU - André, Fabrice
AU - Zitvogel, Laurence
PY - 2002/8/1
Y1 - 2002/8/1
N2 - Exosomes are membrane vesicles of 30 to 100 nm in diameter, of endocytic origin, and are produced and secreted in vitro by living cells of diverse origin. In vivo and in vitro experiments suggest, from their particular proteomic composition, that exosomes are involved in the transfer of tumor antigens to antigen presenting cells, and in the stimulation of a specific immune response. In this review, we provide a molecular characterization of exosomes. The hypotheses accounting for exosome biogenesis will be outlined. Finally, we will describe their bioactivities and discuss their potential relevance and clinical implementation for cancer immunotherapy.
AB - Exosomes are membrane vesicles of 30 to 100 nm in diameter, of endocytic origin, and are produced and secreted in vitro by living cells of diverse origin. In vivo and in vitro experiments suggest, from their particular proteomic composition, that exosomes are involved in the transfer of tumor antigens to antigen presenting cells, and in the stimulation of a specific immune response. In this review, we provide a molecular characterization of exosomes. The hypotheses accounting for exosome biogenesis will be outlined. Finally, we will describe their bioactivities and discuss their potential relevance and clinical implementation for cancer immunotherapy.
KW - Biogenesis
KW - Exosomal functions
KW - Exosomes
KW - Immunotherapy
KW - Proteomic composition
UR - http://www.scopus.com/inward/record.url?scp=0036705466&partnerID=8YFLogxK
M3 - Review article
C2 - 12222875
AN - SCOPUS:0036705466
SN - 1464-8431
VL - 4
SP - 372
EP - 381
JO - Current Opinion in Molecular Therapeutics
JF - Current Opinion in Molecular Therapeutics
IS - 4
ER -